Tirzepatide (Mounjaro)

Community weight management support in Dorset

The new weight management ‘Tirzepatide’ medication (brand name Mounjaro^®) will be available to NHS patients nationally from 23 June.

In Dorset around 1,000 people currently qualify for the medication based on national eligibility criteria – but it won’t be available locally until later this year (autumn) – so please don’t contact your GP just yet as they’re unable to help currently.

Who is eligible?

The first group of people eligible under the national criteria includes individuals who:

• Have a body mass index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)

and

• Have at least four of the following long-term conditions:

• Non-diabetic hyperglycaemia or type 2 diabetes
• Hypertension (high blood pressure)
• Dyslipidaemia
• Established cardiovascular disease
• Obstructive sleep apnoea